News|Articles|June 9, 2025
FSP Outsourcing in Clinical Research: Trends and Opportunities
Author(s)PPD
When drug developers choose the right outsourcing strategies in clinical research, they can gain significant benefits in terms of quality, efficiency, and operational success. In its third annual Functional Service Provider (FSP) Trends Report, Thermo Fisher Scientific’s clinical research business—PPD—gathered insights from 150 global biotech and pharma leaders to determine how FSP models help sponsors address common industry obstacles.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Content
Trending on Applied Clinical Trials Online
1
Verana Health Merges With COTA to Expand Real-World Data Capabilities Across Oncology and Specialty Care
2
Securing Comparator Drugs in Competitive EU Markets: Challenges and Practical Solutions
3
BostonGene Expands AI-Driven Oncology Collaborations with New AstraZeneca Deal
4
Nipocalimab Delivers Positive Phase IIb Results in JASMINE SLE Trial
5